25, 2024 The Lancet, Trajectory of weight regain after cessation of GLP-1 receptor agonists: a systematic review and nonlinear meta-regression, March 2026 UCHealth, Many people using GLP-1 weight loss drugs may not be eating enough nutritious food, May 19, 2025 UCLA Health, Rapid weight loss can lead to loss of muscle mass, May 1, 2024 University of Colorado, The Underappreciated Benefits of GLP-1 Receptor Agonists, Nov
Patient characteristics The baseline characteristics of the participants enrolled in SURPASS2 and SUSTAIN FORTE are summarized in Table 2
But if you think you can inject it weekly and keep eating like garbage while sitting on the couch, youre in for a rude awakening
Previous Weight Management Efforts : Your previous attempts at weight management, including diet, exercise, and other interventions, may be considered by your healthcare provider
Obesity Semaglutide is FDA-approved for weight management in those with a BMI 27 with comorbidities or BMI 30
doi: 10.1111/dom.14944 [DOI] [PubMed] [Google Scholar]
